TCF7L2 rs7906613: What Your Genotype Means
The rs7906613 variant is a specific genetic change located within the TCF7L2 gene. It is widely recognized in scientific literature for its statistical association with an increased risk of developing type 2 diabetes mellitus.
What each genotype means
Lower diabetes risk profile
This genotype is considered the protective version of this variant. Research indicates that individuals with this profile generally have a lower statistical risk of developing type 2 diabetes compared to those carrying the T allele.
This is the most common genotype in many populations, though frequencies vary significantly by ancestry.
Increased diabetes risk profile
Carrying one copy of the T allele is associated with an increased risk of developing type 2 diabetes. Studies suggest this variant may influence blood glucose homeostasis and insulin secretion, though it does not guarantee the development of the condition.
This heterozygous genotype is common, appearing in a significant portion of the population across many ancestral groups.
Higher diabetes risk profile
Carrying two copies of the T allele is associated with the highest statistical risk for type 2 diabetes among these genotypes. Research suggests this may be linked to impaired insulin secretion and altered glucose metabolism, and you should discuss your metabolic health and screening options with your healthcare provider.
This homozygous genotype is less common than the others, typically found in a smaller percentage of the population depending on ethnic background.
Understanding the rs7906613 Variant
The rs7906613 variant is a single nucleotide polymorphism (SNP) situated within the TCF7L2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region of the genome that has been extensively studied due to its strong link to metabolic health. Researchers identify this variant by its unique reference SNP ID (rsID), which acts as a standardized label for scientists to track and compare findings across different studies. Because it is located in a non-coding region of the gene, it does not change the protein structure directly, but it is thought to influence how the TCF7L2 gene is regulated or expressed within the body.
The Role of the TCF7L2 Gene
The TCF7L2 gene encodes a protein called transcription factor 7-like 2. This protein plays a critical role in the Wnt signaling pathway, a complex network of proteins that regulates various cellular processes, including cell growth, differentiation, and survival. In the context of metabolic health, TCF7L2 is highly expressed in the pancreas. Current research suggests that the gene is involved in the regulation of insulin secretion from beta cells. When the function of this gene is altered, it may impair the body's ability to release insulin in response to glucose, which is a hallmark of type 2 diabetes. By influencing how the pancreas responds to blood sugar levels, variations in this gene can contribute to the overall risk profile for metabolic conditions.
Research and Evidence Strength
The association between TCF7L2 variants and type 2 diabetes is considered one of the most robust findings in modern human genetics. Since its initial discovery, numerous large-scale genome-wide association studies (GWAS) and meta-analyses have replicated the link between TCF7L2 polymorphisms and diabetes risk across diverse ancestral groups, including Caucasians, Asians, and African Americans. While the evidence for an association is strong, it is important to note that this variant is not a diagnostic tool. It represents a statistical increase in risk rather than a deterministic cause of disease. Most individuals who carry the risk-associated alleles will not necessarily develop diabetes, as the condition is influenced by a complex interplay of multiple genetic factors, lifestyle choices, diet, and physical activity levels.
What This Information Means for You
Knowing your genotype for rs7906613 provides insight into your genetic predisposition, but it should not be used to diagnose or predict your health outcomes in isolation. Genetic risk is only one piece of a much larger puzzle. If you are concerned about your risk for type 2 diabetes, the most effective approach is to focus on modifiable lifestyle factors such as maintaining a balanced diet, engaging in regular physical activity, and monitoring blood glucose levels as recommended by your healthcare provider. Genetic testing results should always be discussed with a qualified medical professional or a genetic counselor who can help interpret these findings within the context of your personal and family medical history. Never make changes to your health management or medical care based solely on genetic data without professional guidance.
How common is this variant?
The rs7906613 variant is common across many ancestral populations, with minor allele frequencies typically ranging between 20% and 40%.
Frequently asked questions
Does having the risk genotype mean I will get diabetes?
No. Having a risk-associated genotype only indicates a statistical increase in susceptibility. Many people with the risk genotype never develop diabetes, as the disease is heavily influenced by lifestyle and other environmental factors.
Can I change my genetic risk for TCF7L2?
You cannot change your DNA sequence. However, you can manage your overall risk for type 2 diabetes through healthy lifestyle choices, such as maintaining a healthy weight and staying physically active.
Should I get tested for this variant?
Genetic testing for common variants like rs7906613 is generally not recommended for clinical diagnosis. If you are concerned about diabetes, consult your doctor for standard clinical screenings like fasting blood glucose or HbA1c tests.
Is this variant only found in certain ethnicities?
No, this variant is found across many different ancestral populations. While the exact frequency may vary between groups, the association with type 2 diabetes has been observed globally.
Sources & further reading
Educational information only, last refreshed 10/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7906613?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 strongly associated with type 2 diabetes risk and modulation of glycemic response to dietary fiber.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.